Lung Ultrasound for Breathing Difficulties in Newborns
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to determine whether lung ultrasound can predict extubation success in neonates with respiratory distress. Participants will undergo a lung ultrasound pre- and post-extubation.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What data supports the effectiveness of the treatment Ultrasound Imaging for breathing difficulties in newborns?
Is lung ultrasound safe for newborns?
How is lung ultrasound different from other treatments for breathing difficulties in newborns?
Lung ultrasound is unique because it is a noninvasive, bedside imaging technique that helps doctors accurately diagnose and manage breathing problems in newborns without needing to move them to another location. Unlike other treatments that might involve more invasive procedures, lung ultrasound provides real-time information to guide care directly at the bedside.110111213
Research Team
Adam S Bauer, MD
Principal Investigator
Meriter Foundation
Eligibility Criteria
This trial is for infants in the NICU with respiratory distress needing a breathing tube, who are ready to try breathing without it according to their doctor. They must be born at specific hospitals. Babies with major birth defects or those whose parents are minors cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-extubation Assessment
Participants undergo a lung ultrasound 12 hours before extubation to assess readiness
Post-extubation Monitoring
Participants undergo a lung ultrasound and are monitored for extubation success and changes in vital signs
Follow-up
Participants are monitored for safety and effectiveness after extubation, including time to re-intubation
Treatment Details
Interventions
- Ultrasound (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
Robert Drape
University of Wisconsin, Madison
Chief Executive Officer since 2007
Executive MBA from the University of Wisconsin – Madison, Bachelor's degree in Biology from Augustana College (IL)
Dr. Ciara Barclay-Buchanan
University of Wisconsin, Madison
Chief Medical Officer since 2023
MD from Wayne State University School of Medicine
UnityPoint Health-Meriter
Collaborator
Meriter Foundation
Collaborator